Grifols, S.A. ( GRFS) - Key Metrics
GRFS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.75 | $0.23 | $0.33 | $0.16 |
| 2026Q1 | $2.54 | $0.11 | $0.16 | $0.09 |
| 2025Q4 | $2.88 | $0.14 | $0.63 | $0.44 |
| 2025Q3 | $2.74 | $0.19 | $0.48 | $0.38 |
| 2025Q2 | $2.75 | $0.17 | $0.23 | $0.14 |
GRFS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 6.74 |
| 2026Q1 | 0% | 15.77 |
| 2025Q4 | 26.32% | 14.21 |
| 2025Q3 | 80.64% | 11.17 |
| 2025Q2 | 0% | 11.28 |
GRFS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.56% | 0% |
| 2026Q1 | 1.25% | 0% |
| 2025Q4 | 5.48% | 0.47% |
| 2025Q3 | 4.42% | 1.77% |
| 2025Q2 | 1.80% | 0% |
GRFS
Price: $7.80
52 week price:
Dividend Yield: 3.60%
Payout Ratio Range:
Earnings Per Share: 0.76 USD
P/E Ratio: 10.36
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Spain
Volume: 924384
Ebitda: 362.6 millionMarket Capitalization: 6.6 billion
Years Paying Dividends: 2